Claudia Luevano-Contreras

Dr. Claudia Luevano-Contreras

Department of Medical Sciences, University of Guanajuato, Leon
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2010 in Nutrients
Verified
Journal Article
Open access
PDF file
CLClaudia Luevano-Contreras
Claudia Luevano-Contreras
KCKaren Chapman-Novakofski
Karen Chapman-Novakofski
Advanced glycation end products (AGEs) are a heterogeneous, complex group of compounds that are formed when reducing sugar reacts in a non-enzymatic way with amino acids in proteins and other macromolecules. This occurs both exogenously (in food) and endogenously (in humans) with greater concentrations found in older adults. While higher AGEs occur in both healthy older adults and those with chronic diseases, research is progressing to both quantify AGEs in food and in people, and to identify mechanisms that would explain why some human tissues are damaged, and others are not. In the last twenty years, there has been increased evidence that AGEs could be implicated in the development of chronic degenerative diseases of aging, such as cardiovascular disease, Alzheimer’s disease and with complications of diabetes mellitus. Results of several studies in animal models and humans show that the restriction of dietary AGEs has positive effects on wound healing, insulin resistance and cardiovascular diseases. Recently, the effect of restriction in AGEs intake has been reported to increase the lifespan in animal models. This paper will summarize the work that has been published for both food AGEs and in vivo AGEs and their relation with aging, as well as provide suggestions for future research.

1 July 2015 in Advances in Nutrition
Verified
Journal Article
Open access
PDF file
Jaime UribarriJaime Uribarri
Jaime Uribarri
Dolores del CastilloDolores del Castillo
Dolores del Castillo
MMMaría Pía de la Maza
María Pía de la Maza
RFRosana Filip
Rosana Filip
AGAlejandro Gugliucci
Alejandro Gugliucci
MGMa Eugenia Garay-Sevilla
Ma Eugenia Garay-Sevilla
Over the past 2 decades there has been increasing evidence supporting an important contribution from food-derived advanced glycation end products (AG

26 September 2018 in Biomedical Optics Express
Verified
Journal Article
Open access
PDF file
Edgar GuevaraEdgar Guevara
Edgar Guevara
JTJuan Carlos Torres-Galván
Juan Carlos Torres-Galván
MRMiguel G. Ramírez-Elías
Miguel G. Ramírez-Elías
CLClaudia Luevano-Contreras
Claudia Luevano-Contreras
FGFrancisco Gonzalez
Francisco Gonzalez
Type 2 diabetes mellitus (DM2) is one of the most widely prevalent diseases worldwide and is currently screened by invasive techniques based on enzymatic assays that measure plasma glucose concentration in a laboratory setting. A promising plan of action for screening DM2 is to identify molecular signatures in a non-invasive fashion. This work describes the application of portable Raman spectroscopy coupled with several supervised machine-learning techniques, to discern between diabetic patients and healthy controls (Ctrl), with a high degree of accuracy. Using artificial neural networks (ANN), we accurately discriminated between DM2 and Ctrl groups with 88.9–90.9% accuracy, depending on the sampling site. In order to compare the ANN performance to more traditional methods used in spectroscopy, principal component analysis (PCA) was carried out. A subset of features from PCA was used to generate a support vector machine (SVM) model, albeit with decreased accuracy (76.0–82.5%). The 10-fold cross-validation model was performed to validate both classifiers. This technique is relatively low-cost, harmless, simple and comfortable for the patient, yielding rapid diagnosis. Furthermore, the performance of the ANN-based method was better than the typical performance of the invasive measurement of capillary blood glucose. These characteristics make our method a promising screening tool for identifying DM2 in a non-invasive and automated fashion.

1 January 2013 in Journal of Clinical Biochemistry and Nutrition
Verified
Journal Article
Open access
CLClaudia Luevano-Contreras
Claudia Luevano-Contreras
MGMa. Eugenia Garay-Sevilla
Ma. Eugenia Garay-Sevilla
KWKazimierz Wrobel
Kazimierz Wrobel
JMJuan M. Malacara
Juan M. Malacara
KWKatarzyna Wrobel
Katarzyna Wrobel
The augmented consumption of dietary advanced glycation end products (dAGEs) has been associated with increased oxidative stress and inflammation, however, there is insufficient information over the effect on insulin resistance. The objective of the present study is to investigate the effect of dAGEs restriction on tumor necrosis factor-α (TNF-α), malondialdehyde, C-reactive protein (CRP), and insulin resistance in DM2 patients. We carried out a randomized 6 weeks prospective study in two groups of patients: subjects with a standard diet (n = 13), vs low dAGEs (n = 13). At the beginning and the end of study, we collected anthropometric measurements, and values of circulating glucose, HbA1c, lipids, insulin, serum AGEs, CRP, TNF-α and malondialdehyde. Anthropometric measurements, glucose, and lipids were similar in both groups at base line and at the end of the study. Estimation of basal dAGEs was similar in both groups; after 6 weeks it was unchanged in the standard group but in the low dAGEs group decreased by 44% (p<0.0002). Changes in TNF-α levels were different under standard diet (12.5 ± 14.7) as compared with low dAGEs (-18.36 ± 17.1, p<0.00001); changes in malondialdehyde were different in the respective groups (2.0 ± 2.61 and -0.83 ± 2.0, p<0.005) no changes were found for insulin levels or HOMA-IR. In conclusion, The dAGEs restriction decreased significantly TNF-α and malondialdehyde levels.

10 July 2017 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
CLClaudia Luevano-Contreras
Claudia Luevano-Contreras
AGArmando Gómez-Ojeda
Armando Gómez-Ojeda
MMMaciste Habacuc Macías-Cervantes
Maciste Habacuc Macías-Cervantes
MGMa. Eugenia Garay-Sevilla
Ma. Eugenia Garay-Sevilla

1 March 2018 in Food Chemistry
Verified
Journal Article
Closed access
AGArmando Gómez-Ojeda
Armando Gómez-Ojeda
SJSarahi Jaramillo-Ortíz
Sarahi Jaramillo-Ortíz
KWKatarzyna Wrobel
Katarzyna Wrobel
KWKazimierz Wrobel
Kazimierz Wrobel
GBGloria Barbosa-Sabanero
Gloria Barbosa-Sabanero
MGMa. Eugenia Garay-Sevilla
Ma. Eugenia Garay-Sevilla